Iovance Biotherapeutics (IOVA)
(Delayed Data from NSDQ)
$10.46 USD
+0.70 (7.17%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $10.40 -0.06 (-0.57%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
IOVA 10.46 +0.70(7.17%)
Will IOVA be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for IOVA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IOVA
Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?
Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View
IOVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
Kronos Bio, Inc. (KRON) Expected to Beat Earnings Estimates: Should You Buy?
AquaBounty Technologies, Inc. (AQB) Reports Q2 Loss, Tops Revenue Estimates
Other News for IOVA
Buy Stocks Now, Here Are 3 Categories
IOVA Makes Bullish Cross Above Critical Moving Average
Undercovered Dozen: Clover Health, Quipt, Vital Energy, STMicroelectronics +
Iovance Biotherapeutics: Moving To The Next Phase
Perceptive Advisors LLC Acquires New Stake in Instil Bio Inc